Patents by Inventor Yaping Ma
Yaping Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11688381Abstract: The present disclosure presents a feedback active noise control system and strategy with online secondary-path modeling, and belongs to the technical field of active noise control. The linear prediction subsystem takes the residual noise as its input and separates the remaining sinusoidal noise from the broadband noise. The remaining sinusoidal noise is used effectively not only to update the controller but also to scale the auxiliary noise, while the broadband noise serves as a desired input of online secondary-path modeling subsystem. In this way, the coupling between the controller and the online secondary-path modeling subsystem is significantly mitigated, leading to both faster convergence and improved noise reduction performance. A practical scheme for refreshing the entire system is also developed to enhance its robustness against even abrupt changes with the secondary path or the primary noise.Type: GrantFiled: November 1, 2022Date of Patent: June 27, 2023Assignee: JIANGNAN UNIVERSITYInventors: Yaping Ma, Yegui Xiao, Dinghui Wu, Linbo Xie, Xin Wang
-
Patent number: 11628432Abstract: The invention discloses a nitrogen-doped mesoporous carbon-coated Titanium dioxide composite photocatalyst, a preparation method and use thereof. The preparation method comprises the steps of: dissolving an organic ligand and Ti(OC3H7)4 in a mixture of methanol and DMF at a certain ratio, performing a hydrothermal reaction, centrifuging and drying to obtain a Titanium-based metal organic framework (Ti-MOF); pyrolyzing the obtained Ti-MOF under an inert atmosphere, and oxidizing the same for etching to obtain a nitrogen-doped mesoporous carbon-coated Titanium dioxide composite photocatalyst. The obtained composite photocatalyst not only facilitates the adsorption, enrichment and mass transfer of low concentration VOCs, but also efficiently degrades VOCs under sunlight. It has high degradation activity and stability when performing photocatalytic removal of VOCs in the presence of visible light, is simple in synthesis, low in preparation cost, and has strong potential for the use in environmental protection.Type: GrantFiled: April 13, 2018Date of Patent: April 18, 2023Assignee: GUANGDONG UNIVERSITY OF TECHNOLOGYInventors: Hongli Liu, Yaping Ma, Taicheng An, Guiying Li, Jiangyao Chen
-
Publication number: 20230077396Abstract: The present disclosure presents a feedback active noise control system and strategy with online secondary-path modeling, and belongs to the technical field of active noise control. The linear prediction subsystem takes the residual noise as its input and separates the remaining sinusoidal noise from the broadband noise. The remaining sinusoidal noise is used effectively not only to update the controller but also to scale the auxiliary noise, while the broadband noise serves as a desired input of online secondary-path modeling subsystem. In this way, the coupling between the controller and the online secondary-path modeling subsystem is significantly mitigated, leading to both faster convergence and improved noise reduction performance. A practical scheme for refreshing the entire system is also developed to enhance its robustness against even abrupt changes with the secondary path or the primary noise.Type: ApplicationFiled: November 1, 2022Publication date: March 16, 2023Inventors: Yaping MA, Yegui Xiao, Dinghui Wu, Linbo Xie, Xin Wang
-
Publication number: 20210357078Abstract: A touch panel, a method for manufacturing the same and a display device are provided in the disclosure. The method for manufacturing the touch panel includes: forming a first conductive layer on a base substrate; performing a patterning process on the first conductive layer to form a first conductive layer pattern, wherein the first conductive layer pattern includes two etched regions and a non-etched region which are formed at a preset intersection position where a first touch electrode and a second touch electrode intersect with each other; forming an insulation pattern at the preset intersection position, wherein the insulation pattern is filled in the two etched regions and covers the non-etched region; forming a second conductive layer, wherein the first conductive layer and the second conductive layer constitute a conductive layer; and performing a patterning process on the conductive layer.Type: ApplicationFiled: June 25, 2019Publication date: November 18, 2021Inventors: Yadong YUAN, Weijie MA, Pengyu ZHANG, Haifeng HU, Jun CHEN, Yaping MA, Yangjie LI, Cui CHEN, Xue CHENG
-
Publication number: 20210121864Abstract: The invention discloses a nitrogen-doped mesoporous carbon-coated Titanium dioxide composite photocatalyst, a preparation method and use thereof. The preparation method comprises the steps of: dissolving an organic ligand and Ti(OC3H7)4 in a mixture of methanol and DMF at a certain ratio, performing a hydrothermal reaction, centrifuging and drying to obtain a Titanium-based metal organic framework (Ti-MOF); pyrolyzing the obtained Ti-MOF under an inert atmosphere, and oxidizing the same for etching to obtain a nitrogen-doped mesoporous carbon-coated Titanium dioxide composite photocatalyst. The obtained composite photocatalyst not only facilitates the adsorption, enrichment and mass transfer of low concentration VOCs, but also efficiently degrades VOCs under sunlight. It has high degradation activity and stability when performing photocatalytic removal of VOCs in the presence of visible light, is simple in synthesis, low in preparation cost, and has strong potential for the use in environmental protection.Type: ApplicationFiled: April 13, 2018Publication date: April 29, 2021Inventors: Hongli Liu, Yaping Ma, Taicheng An, Guiying Li, Jiangyao Chen
-
Patent number: 10577394Abstract: Disclosed is a method for preparing ganirelix acetate. The method includes the following steps: respectively replacing Fmoc-HArg(Et)2-OH and Fmoc-D-HArg(Et)2-OH by employing Fmoc-Lys(Boc)-OH and Fmoc-D-Lys(Boc)-OH or Fmoc-Lys(Alloc)-OH and Fmoc-D-Lys(Alloc)-OH; synthesizing a ganirelix precursor I or ganirelix precursor II-peptide resin in advance; and then respectively performing modifications and treatments on side chain amino groups of Lys and D-Lys in the precursor I or the precursor II-peptide resin to obtain ganirelix acetate. The ganirelix acetate synthesized therefrom is high in purity, has few impurities and a relatively low cost, and is suitable for large-scale production.Type: GrantFiled: June 12, 2015Date of Patent: March 3, 2020Assignee: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Youjin Chen, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Patent number: 10259909Abstract: The present invention discloses a method for preparing glatiramer acetate, comprising: (1) dissolving L-alanine NCA, L-tyrosine NCA, L-glutamic acid-?-benzyl ester NCA, and L-?-trifluoroacetyl-lysine NCA in 1,4-dioxane as solvent, stirring until a clarified solution is formed; (2) adding diethylamine for catalysis, stirring at 20-25° C., then slowly pouring the reaction solution into water, collecting the produced white product; (3) adding the obtained product to a solution of hydrobromic acid in acetic acid, stirring at 23.0-25.0° C., pouring the reaction solution into purified water for quenching and stirring, subjecting the mixture to suction filtration to obtain a yellow solid, after repeating 3-5 times, subjecting the solid to blast drying to remove the moisture therein; and (4) dissolving the solid obtained in step (3) in a 1M piperidine aqueous solution at room temperature and stirring, subjecting the obtained solution to dialysis, adding glacial acetic acid to adjust the pH to 5.5-7.Type: GrantFiled: November 26, 2015Date of Patent: April 16, 2019Assignee: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Huixing Yuan, Guotao Li, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Publication number: 20170298180Abstract: The present invention discloses a method for preparing glatiramer acetate, comprising: (1) dissolving L-alanine NCA, L-tyrosine NCA, L-glutamic acid-?-benzyl ester NCA, and L-?-trifluoroacetyl-lysine NCA in 1,4-dioxane as solvent, stirring until a clarified solution is formed; (2) adding diethylamine for catalysis, stirring at 20-25° C., then slowly pouring the reaction solution into water, collecting the produced white product; (3) adding the obtained product to a solution of hydrobromic acid in acetic acid, stirring at 23.0-25.0° C., pouring the reaction solution into purified water for quenching and stirring, subjecting the mixture to suction filtration to obtain a yellow solid, after repeating 3-5 times, subjecting the solid to blast drying to remove the moisture therein; and (4) dissolving the solid obtained in step (3) in a 1M piperidine aqueous solution at room temperature and stirring, subjecting the obtained solution to dialysis, adding glacial acetic acid to adjust the pH to 5.5-7.Type: ApplicationFiled: November 26, 2015Publication date: October 19, 2017Applicant: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Huixing YUAN, Guotao LI, Jian LIU, Yaping MA, Jiancheng YUAN
-
Publication number: 20170121371Abstract: Disclosed is a method for preparing ganirelix acetate. The method includes the following steps: respectively replacing Fmoc-HArg(Et)2-OH and Fmoc-D-HArg(Et)2-OH by employing Fmoc-Lys(Boc)-OH and Fmoc-D-Lys(Boc)-OH or Fmoc-Lys(Alloc)-OH and Fmoc-D-Lys(Alloc)-OH; synthesizing a ganirelix precursor I or ganirelix precursor II-peptide resin in advance; and then respectively performing modifications and treatments on side chain amino groups of Lys and D-Lys in the precursor I or the precursor II-peptide resin to obtain ganirelix acetate. The ganirelix acetate synthesized therefrom is high in purity, has few impurities and a relatively low cost, and is suitable for large-scale production.Type: ApplicationFiled: June 12, 2015Publication date: May 4, 2017Inventors: Youjin CHEN, Jian LIU, Yaping MA, Jiancheng YUAN
-
Patent number: 9637517Abstract: Disclosed in the present invention is a method for preparing Exenatide. Serine resin is obtained through a first coupling of serine and resin and successively with amino acids through a second coupling to obtain a peptide resin with a sequence as shown by SEQ ID No. 1; Exenatide resin is obtained through a third coupling of histidine containing a protecting group or salts thereof and the peptide resin with a sequence as shown by SEQ ID No. 1, then it is cracked and purified to obtain purified Exenatide peptide. The method for preparing Exenatide of the present invention inhibits the formation of D-His-Exenatide, and thereby improves the yield and purity of Exenatide.Type: GrantFiled: October 31, 2012Date of Patent: May 2, 2017Assignee: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Pengcheng Mi, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Patent number: 9562071Abstract: Provided is a method for preparing eptifibatide, wherein the method comprises: obtaining an eptifibatide refined peptide solution; and obtaining and freeze-drying an eptifibatide refined peptide concentrate after rotary evaporation of the eptifibatide refined peptide solution, wherein the concentration of the eptifibatide refined peptide concentrate is 15-30 mg/ml and the temperature of rotary evaporation is 251° C.-35° C. The preparation method of the eptifibatide refined peptide solution is as follows: coupling Cys with a resin to obtain a Cys-resin; obtaining a polypeptide having a sequence as represented by SEQ ID NO: 1 by gradually coupling the Cys-resin with Pro, Trp, Asp, Gly, Har and Mpa; and obtaining the eptifibatide refined peptide solution through oxidation, cleavage, purification and transfer to salt.Type: GrantFiled: June 16, 2014Date of Patent: February 7, 2017Assignee: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Xu Kang, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Patent number: 9434767Abstract: The present invention provides a method for preparing atosiban acetate. The method comprises the following steps of: synthesizing to obtain linear atosiban; dissolving the linear atosiban in an acetonitrile aqueous solution, adjusting the pH value with ammonia water, adding H2O2 for oxidizing, filtering, purifying, and transferring salt to obtain the atosiban acetate. In the present invention, an appropriate route is provided, the linear atosiban is synthesized by adopting a solid phase method, and the atosiban is obtained by liquid phase oxidation. The method has the advantages of capabilities of solving the problem of insolubility of the linear atosiban, reducing the reaction size to the maximum extent and shortening reaction time, and being high in yield and easy to industrialize.Type: GrantFiled: December 22, 2011Date of Patent: September 6, 2016Assignee: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Qing Xiao, Jian Liu, Hongling Li, Yaping Ma, Jiancheng Yuan
-
Publication number: 20160222059Abstract: Provided is a method for preparing eptifibatide, wherein the method comprises: obtaining an eptifibatide refined peptide solution; and obtaining and freeze-drying an eptifibatide refined peptide concentrate after rotary evaporation of the eptifibatide refined peptide solution, wherein the concentration of the eptifibatide refined peptide concentrate is 15-30 mg/ml and the temperature of rotary evaporation is 251° C.-35° C. The preparation method of the eptifibatide refined peptide solution is as follows: coupling Cys with a resin to obtain a Cys-resin; obtaining a polypeptide having a sequence as represented by SEQ ID NO: 1 by gradually coupling the Cys-resin with Pro, Trp, Asp, Gly, Har and Mpa; and obtaining the eptifibatide refined peptide solution through oxidation, cleavage, purification and transfer to salt.Type: ApplicationFiled: June 16, 2014Publication date: August 4, 2016Applicant: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Xu KANG, Jian LIU, Yaping MA, Jiancheng YUAN
-
Patent number: 9260474Abstract: Provided is a method for solid phase synthesis of liraglutide, comprising the following steps: A), Fmoc-Gly-resin being obtained by coupling resin solid phase carrier with glycine with N-end protected by Fmoc(Fmoc-Gly-OH) in the presence of activator system; B) according to the peptide sequence of the main chain of liraglutide, successively coupling with amino acids with N-ends protected by Fmoc and protected side chains by the method for solid phase synthesis, wherein lysine employs Fmoc-Lys(Alloc)-OH; C) removing the protective group, Alloc, from the side chain of lysine; D) coupling the side chain of lysine with Palmitoyl-Glu-OtBu by the method for solid phase synthesis; E) cleavage, removing protection groups and resin to obtain crude liraglutide; F) purifying and lyophilizing to obtain liraglutide.Type: GrantFiled: August 30, 2012Date of Patent: February 16, 2016Assignee: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Junfeng Pan, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Publication number: 20150232503Abstract: Disclosed in the present invention is a method for preparing Exenatide. Serine resin is obtained through a first coupling of serine and resin and successively with amino acids through a second coupling to obtain a peptide resin with a sequence as shown by SEQ ID No. 1; Exenatide resin is obtained through a third coupling of histidine containing a protecting group or salts thereof and the peptide resin with a sequence as shown by SEQ ID No. 1, then it is cracked and purified to obtain purified Exenatide peptide. The method for preparing Exenatide of the present invention inhibits the formation of D-His-Exenatide, and thereby improves the yield and purity of Exenatide.Type: ApplicationFiled: October 31, 2012Publication date: August 20, 2015Applicant: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Pengcheng Mi, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Publication number: 20150051372Abstract: The present invention relates to the field of biomedicine, and in particular, to a method for purifying solid-phase synthetic crude liraglutide. The method comprises: dissolving solid-phase synthetic crude liraglutide in an aqueous acetonitrile solution to obtain a crude peptide solution; and obtaining liraglutide with high purity and high yield through four-step HPLC purification.Type: ApplicationFiled: January 29, 2013Publication date: February 19, 2015Applicant: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Liangzheng Qin, Junfeng Pan, Yaping Ma, Jiancheng Yuan
-
Publication number: 20140350219Abstract: Provided is a method for solid phase synthesis of liraglutide, comprising the following steps: A), Fmoc-Gly-resin being obtained by coupling resin solid phase carrier with glycine with N-end protected by Fmoc(Fmoc-Gly-OH) in the presence of activator system; B) according to the peptide sequence of the main chain of liraglutide, successively coupling with amino acids with N-ends protected by Fmoc and protected side chains by the method for solid phase synthesis, wherein lysine employs Fmoc-Lys(Alloc)-OH; C) removing the protective group, Alloc, from the side chain of lysine; D) couplilng the side chain of lysine with Palmitoyl-Glu-Offiu by the method for solid phase synthesis; E) cleavage, removing protection groups and resin to obtain crude liraglutide; F) purifying and lyophilizing to obtain liraglutide.Type: ApplicationFiled: August 30, 2012Publication date: November 27, 2014Applicant: HYBIO PHARMACEUTICAL CO., LTD.Inventors: Junfeng Pan, Jian Liu, Yaping Ma, Jiancheng Yuan
-
Publication number: 20130261285Abstract: The present invention provides a method for preparing atosiban acetate. The method comprises the following steps of: synthesizing to obtain linear atosiban; dissolving the linear atosiban in an acetonitrile aqueous solution, adjusting the pH value with ammonia water, adding H2O2 for oxidizing, filtering, purifying, and transferring salt to obtain the atosiban acetate. In the present invention, an appropriate route is provided, the linear atosiban is synthesized by adopting a solid phase method, and the atosiban is obtained by liquid phase oxidation. The method has the advantages of capabilities of solving the problem of insolubility of the linear atosiban, reducing the reaction size to the maximum extent and shortening reaction time, and being high in yield and easy to industrialize.Type: ApplicationFiled: December 22, 2011Publication date: October 3, 2013Inventors: Qing Xiao, Jian Liu, Hongling Li, Yaping Ma, Jiancheng Yuan